These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29386825)

  • 1. Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study.
    Kong SH; Suh HS; Choi YS
    Ann Dermatol; 2018 Feb; 30(1):1-7. PubMed ID: 29386825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of dual-pulsed 1064 nm Q-switched Nd:YAG laser and single-pulsed 1064 nm Q-switched Nd:YAG laser by using zebrafish model and prospective split-face analysis of facial melasma.
    Jang HW; Chun SH; Park HC; Ryu HJ; Kim IH
    J Cosmet Laser Ther; 2017 Apr; 19(2):114-123. PubMed ID: 27911108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A split-face comparison of low-fluence Q-switched Nd: YAG laser plus 1550 nm fractional photothermolysis vs. Q-switched Nd: YAG monotherapy for facial melasma in Asian skin.
    Kim HS; Kim EK; Jung KE; Park YM; Kim HO; Lee JY
    J Cosmet Laser Ther; 2013 Jun; 15(3):143-9. PubMed ID: 23607714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
    Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
    Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy.
    Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE
    J Cosmet Laser Ther; 2015 Feb; 17(1):2-8. PubMed ID: 25151913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermoscopy as a useful tool for evaluating melasma and assessing the response to 1064-nm Q-switched Nd:YAG laser.
    Abdel Hay R; Mohammed FN; Sayed KS; Abd El Fattah NA; Ibrahim S
    Dermatol Ther; 2020 Jul; 33(4):e13629. PubMed ID: 32431000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
    Ustuner P; Balevi A; Ozdemir M
    J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Toning Method with the Combination of Picosecond and Microsecond Nd:YAG in Refractory Melasma Unresponsive to Picosecond Alone.
    Hai L; Phuong B; Ha L; Lam V; Van B; Al-Niaimi F
    J Cutan Aesthet Surg; 2021; 14(1):101-106. PubMed ID: 34084016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study between oral tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation.
    Agamia N; Apalla Z; Salem W; Abdallah W
    J Dermatolog Treat; 2021 Nov; 32(7):819-826. PubMed ID: 31908179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment of melasma involving low-fluence Q-switched Nd:YAG laser and fractional microneedling radiofrequency.
    Kwon HH; Choi SC; Jung JY; Park GH
    J Dermatolog Treat; 2019 Jun; 30(4):352-356. PubMed ID: 30160539
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-fluence Q-switched Nd:YAG laser for the treatment of melasma in Asian patients.
    Choi JE; Lee DW; Seo SH; Ahn HH; Kye YC
    J Cosmet Dermatol; 2018 Dec; 17(6):1053-1058. PubMed ID: 30280474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial.
    Ibrahim SMA; Farag AS; Ali MS; El-Gendy WMAF
    Lasers Surg Med; 2021 Dec; 53(10):1341-1347. PubMed ID: 34101206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study.
    Guo X; Cai X; Jin Y; Zhang T; Wang B; Li Q
    Oncol Lett; 2019 Oct; 18(4):4136-4143. PubMed ID: 31516612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
    Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
    Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation.
    Hawwam SA; Ismail M; El-Attar YA
    Lasers Med Sci; 2022 Jun; 37(4):2193-2201. PubMed ID: 34988730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of melasma with a low-fluence 1064 nm Q-switched Nd:YAG laser: Laser toning in Caucasian women.
    Micek I; Pawlaczyk M; Kroma A; Seraszek-Jaros A; Urbańska M; Gornowicz-Porowska J
    Lasers Surg Med; 2022 Mar; 54(3):366-373. PubMed ID: 34473361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma.
    Suh KS; Sung JY; Roh HJ; Jeon YS; Kim YC; Kim ST
    J Dermatolog Treat; 2011 Aug; 22(4):233-8. PubMed ID: 20443754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Picosecond and Nanosecond Nd:YAG 1064-nm Lasers in the Treatment of Melasma: A Split-Face Randomized Clinical Trial.
    Feng J; Huang L
    Plast Reconstr Surg; 2023 Apr; 151(4):772-777. PubMed ID: 36729879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split-face trial.
    Park SJ; Park JW; Seo SJ; Park KY
    Dermatol Ther; 2022 Mar; 35(3):e15287. PubMed ID: 34962047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.